Story by: Anna V. Bite, D.O. on March 31, 2020
COVID-19 may have certain implications for people who take common medications prescribed for patients with multiple sclerosis (MS). Here’s a breakdown of some MS drugs and the related implications from COVID-19 (before changing their MS treatments, patients should contact their MS specialist).
Both also may increase a person’s risk of getting upper respiratory infections, like COVID-19.
Patients on these drugs have their lymphocyte counts monitored regularly and if found to be low, may be at an increased risk of infection.
Anna V. Bite, D.O., is a neurologist with Norton Neuroscience Institute and has a special interest in MS and other inflammatory diseases of the central nervous system.
Select an appointment date and time from available spots listed below.